Bio-Reference Labs (BRLI) Tops Q2 EPS by 5c

Bio-Reference Labs (NASDAQ: BRLI) reported Q2 EPS of $0.37, $0.05 better than the analyst estimate of $0.32. Revenue for the quarter came in at $201.4 thousand versus the consensus estimate of $195.64 thousand.

For earnings history and earnings-related data on Bio-Reference Labs (BRLI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat